Preparation, characterization, and toxicity assessment of carfilzomib-loaded nickel-based metal-organic framework: Evidence from in-vivo and in-vitro experiments

[1]  A. Díez-Pascual,et al.  Nanoscale MOFs as an advanced tool for medical applications: Challenges and recent progress , 2022, Applied Organometallic Chemistry.

[2]  H. Beitollahi,et al.  Simultaneous Determination of Dopamine and Uric Acid in Real Samples Using a Voltammetric Nanosensor Based on Co-MOF, Graphene Oxide, and 1-Methyl-3-butylimidazolium Bromide , 2022, Micromachines.

[3]  H. Forootanfar,et al.  Facile Microwave-Assisted Biosynthesis of Arsenic Nanoparticles and Evaluation their Antioxidant Properties and Cytotoxic Effects: A Preliminary in Vitro Study , 2022, Journal of Cluster Science.

[4]  S. Ghorbanian,et al.  Preparation of a pH‐responsive chitosan‐montmorillonite‐nitrogen‐doped carbon quantum dots nanocarrier for attenuating doxorubicin limitations in cancer therapy , 2022, Engineering in life sciences.

[5]  S. Pandey,et al.  UiO-66 metal-organic framework nanoparticles as gifted MOFs to the biomedical application: A comprehensive review , 2022, Journal of Drug Delivery Science and Technology.

[6]  A. Díez-Pascual,et al.  Chitosan/Gamma-Alumina/Fe3O4@5-FU Nanostructures as Promising Nanocarriers: Physiochemical Characterization and Toxicity Activity , 2022, Molecules.

[7]  K. Akhbari,et al.  MOF-801 as a Nanoporous Water-Based Carrier System for In Situ Encapsulation and Sustained Release of 5-FU for Effective Cancer Therapy. , 2022, Inorganic chemistry.

[8]  Binghong Luo,et al.  Hyaluronic Acid Modified Halloysite Nanotubes Decorated with ZIF-8 Nanoparticles as Dual Chemo- and Photothermal Anticancer Agents , 2022, ACS Applied Nano Materials.

[9]  Ling Zhang,et al.  Hierarchical MOF-on-MOF Architecture for pH/GSH-Controlled Drug Delivery and Fe-Based Chemodynamic Therapy. , 2022, Inorganic chemistry.

[10]  F. Ameen,et al.  Antioxidant, antibacterial and anticancer efficacy of Alternaria chlamydospora-mediated gold nanoparticles , 2022, Applied Nanoscience.

[11]  S. Ju,et al.  Biodegradable Metal–Organic‐Framework‐Gated Organosilica for Tumor‐Microenvironment‐Unlocked Glutathione‐Depletion‐Enhanced Synergistic Therapy , 2021, Advanced materials.

[12]  P. Karimi,et al.  Pluronic F127/carfilzomib-based nanomicelles as promising nanocarriers: synthesis, characterization, biological, and in silico evaluations , 2021, Journal of Molecular Liquids.

[13]  F. Baino,et al.  In vitro and in vivo anticancer effect of pH-responsive paclitaxel-loaded niosomes , 2021, Journal of Materials Science: Materials in Medicine.

[14]  I. Sheikhshoaie,et al.  Fabrication of a sensitive sensor for determination of xanthine in the presence of uric acid and ascorbic acid by modifying a carbon paste sensor with Fe3O4@Au core–shell and an ionic liquid , 2021, Journal of Food Measurement and Characterization.

[15]  A. Es‐haghi,et al.  MOF-Mediated Synthesis of CuO/CeO2 Composite Nanoparticles: Characterization and Estimation of the Cellular Toxicity against Breast Cancer Cell Line (MCF-7) , 2021, Journal of functional biomaterials.

[16]  S. Pandey,et al.  Simulation, In Vitro, and In Vivo Cytotoxicity Assessments of Methotrexate-Loaded pH-Responsive Nanocarriers , 2021, Polymers.

[17]  T. Karpiński,et al.  Nanoparticles for Cancer Therapy: Current Progress and Challenges , 2021, Nanoscale Research Letters.

[18]  Wei Wang,et al.  Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy , 2021, International journal of nanomedicine.

[19]  Hossein Ghahramani Almanghadim,et al.  Application of nanoparticles in cancer therapy with an emphasis on cell cycle , 2021, Cell biology international.

[20]  T. A. Tabish,et al.  Graphene quantum dot-based electrochemical biosensing for early cancer detection , 2021 .

[21]  Wing‐Fu Lai,et al.  Property-Tuneable Microgels Fabricated by Using Flow-Focusing Microfluidic Geometry for Bioactive Agent Delivery , 2021, Pharmaceutics.

[22]  Wing‐Fu Lai.  Development of Hydrogels with Self-Healing Properties for Delivery of Bioactive Agents. , 2021, Molecular pharmaceutics.

[23]  S. Sargazi,et al.  F127/Cisplatin Microemulsions: In Vitro, In Vivo and Computational Studies , 2021, Applied Sciences.

[24]  H. Rashedi,et al.  Ameliorating quercetin constraints in cancer therapy with pH-responsive agarose-polyvinylpyrrolidone -hydroxyapatite nanocomposite encapsulated in double nanoemulsion. , 2021, International journal of biological macromolecules.

[25]  R. Sheervalilou,et al.  Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review , 2021, Journal of Neuro-Oncology.

[26]  F. Ameen,et al.  Padina boryana mediated green synthesis of crystalline palladium nanoparticles as potential nanodrug against multidrug resistant bacteria and cancer cells , 2021, Scientific Reports.

[27]  X. Wen,et al.  MgFe‐LDH Nanoparticles: A Promising Leukemia Inhibitory Factor Replacement for Self‐Renewal and Pluripotency Maintenance in Cultured Mouse Embryonic Stem Cells , 2021, Advanced science.

[28]  D. Velauthapillai,et al.  Anti-cancer applications of Zr, Co, Ni-doped ZnO thin nanoplates , 2021 .

[29]  H. Fatoorehchi,et al.  Preparation of pH-sensitive chitosan/polyvinylpyrrolidone/α-Fe2O3 nanocomposite for drug delivery application: Emphasis on ameliorating restrictions. , 2021, International journal of biological macromolecules.

[30]  P. Taboada,et al.  Newly crocin-coated magnetite nanoparticles induce apoptosis and decrease VEGF expression in breast carcinoma cells , 2020 .

[31]  Jiye Cai,et al.  Cobalt Oxide Nanoparticle-Synergized Protein Degradation and Phototherapy for Enhanced Anticancer Therapeutics. , 2020, Acta biomaterialia.

[32]  Min Jae Lee,et al.  Ternary Polypeptide Nanoparticles with Improved Encapsulation, Sustained Release, and Enhanced In Vitro Efficacy of Carfilzomib , 2020, Pharmaceutical Research.

[33]  J. Iovanna,et al.  Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib , 2020, Clinical Cancer Research.

[34]  Maili Liu,et al.  Hyperpolarized Xe NMR signal advancement by metal-organic framework entrapment in aqueous solution , 2020, Proceedings of the National Academy of Sciences.

[35]  S. Sargazi,et al.  Hydro-alcoholic Extract of Achillea Wilhelmsii C. Koch Reduces the Expression of Cell Death-Associated Genes while Inducing DNA Damage in HeLa Cervical Cancer Cells , 2020, Iranian journal of medical sciences.

[36]  Z. Zhong,et al.  A6 Peptide-Tagged Core-Disulfide-Crosslinked Micelles for Targeted Delivery of Proteasome Inhibitor Carfilzomib to Multiple Myeloma in Vivo. , 2020, Biomacromolecules.

[37]  Jean-François Hochepied,et al.  Challenges in sample preparation for measuring nanoparticles size by scanning electron microscopy from suspensions, powder form and complex media , 2020 .

[38]  J. Chen,et al.  Nanoporous Gold Embedded ZIF Composite for Enhanced Electrochemical Nitrogen Fixation. , 2019, Angewandte Chemie.

[39]  S. Sargazi,et al.  Carfilzomib Induces Drug Resistance in A2780 Ovarian Cancer Cells Through p53-Dependent and Caspase-3 Independent Pathways , 2019, Journal of Applied Biotechnology Reports.

[40]  K. Kang,et al.  Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Min Jae Lee,et al.  Development of Novel Epoxyketone-Based Proteasome Inhibitors as a Strategy To Overcome Cancer Resistance to Carfilzomib and Bortezomib. , 2019, Journal of medicinal chemistry.

[42]  I. Nijhof,et al.  Carfilzomib for relapsed and refractory multiple myeloma , 2019, Cancer management and research.

[43]  M. Hajizadeh,et al.  Effects of carfilzomib alone and in combination with cisplatin on the cell death in cisplatin-sensitive and cisplatin-resistant ovarian carcinoma cell lines. , 2019, Bratislavske lekarske listy.

[44]  A. Salimi,et al.  Ni-hemin metal–organic framework with highly efficient peroxidase catalytic activity: toward colorimetric cancer cell detection and targeted therapeutics , 2018, Journal of Nanobiotechnology.

[45]  S. Sumathi,et al.  Aegle marmelos leaves extract mediated synthesis of zinc ferrite: Antibacterial activity and drug delivery , 2018, Materials Research Express.

[46]  Saji Uthaman,et al.  Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications , 2018, Biomaterials Research.

[47]  O. B. Usta,et al.  Dose-, treatment- and time-dependent toxicity of superparamagnetic iron oxide nanoparticles on primary rat hepatocytes. , 2018, Nanomedicine.

[48]  Huan Wang,et al.  Enhanced Glioblastoma Targeting Ability of Carfilzomib Enabled by a DA7R-Modified Lipid Nanodisk. , 2018, Molecular pharmaceutics.

[49]  Xiang Zhou,et al.  Metal-organic frameworks for precise inclusion of single-stranded DNA and transfection in immune cells , 2018, Nature Communications.

[50]  Xiao Xiao,et al.  Facile synthesis of ultrathin Ni-MOF nanobelts for high-efficiency determination of glucose in human serum. , 2017, Journal of materials chemistry. B.

[51]  Ying-Wei Yang,et al.  Metal–Organic Framework (MOF)‐Based Drug/Cargo Delivery and Cancer Therapy , 2017, Advanced materials.

[52]  S. Wuttke,et al.  Positioning metal-organic framework nanoparticles within the context of drug delivery - A comparison with mesoporous silica nanoparticles and dendrimers. , 2017, Biomaterials.

[53]  Sumant Saini,et al.  Nanoporous metal organic frameworks as hybrid polymer-metal composites for drug delivery and biomedical applications. , 2017, Drug discovery today.

[54]  T. T. ten Hagen,et al.  Inhomogeneous crystal grain formation in DPPC‐DSPC based thermosensitive liposomes determines content release kinetics , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[55]  Qianqian Zhu,et al.  Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis. , 2017, ACS nano.

[56]  Y. Bae,et al.  Polymer Micelle Formulations of Proteasome Inhibitor Carfilzomib for Improved Metabolic Stability and Anticancer Efficacy in Human Multiple Myeloma and Lung Cancer Cell Lines , 2015, The Journal of Pharmacology and Experimental Therapeutics.

[57]  Jonathan D. Ashley,et al.  Liposomal carfilzomib nanoparticles effectively target multiple myeloma cells and demonstrate enhanced efficacy in vivo. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[58]  Z. Su,et al.  Metal-organic frameworks as potential drug delivery systems , 2013, Expert opinion on drug delivery.

[59]  Jennifer L. Thompson.  Carfilzomib: A Second-Generation Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma , 2013, The Annals of pharmacotherapy.

[60]  M. Bennett,et al.  Pharmacokinetics, Pharmacodynamics, Metabolism, Distribution, and Excretion of Carfilzomib in Rats , 2011, Drug Metabolism and Disposition.

[61]  S. Sahoo,et al.  Cancer nanotechnology: application of nanotechnology in cancer therapy. , 2010, Drug discovery today.

[62]  Gérard Férey,et al.  Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. , 2010, Nature materials.

[63]  Fahima Dilnawaz,et al.  Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. , 2009, Biomaterials.

[64]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .

[65]  S. Parveen,et al.  Polymeric nanoparticles for cancer therapy , 2008, Journal of drug targeting.

[66]  B. Rieger,et al.  Paddle-Wheel Zinc Carboxylate Clusters as Building Units for Metal-Organic Frameworks , 2007 .

[67]  T. Lister,et al.  The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines. , 2007, Cancer research.

[68]  G. Férey,et al.  Metal-organic frameworks: the young child of the porous solids family , 2007 .

[69]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[70]  S. Aust,et al.  Microsomal lipid peroxidation. , 1978, Methods in enzymology.